4.7 Review

Hydrogen sulfide in the regulation of insulin secretion and insulin sensitivity: Implications for the pathogenesis and treatment of diabetes mellitus

Journal

BIOCHEMICAL PHARMACOLOGY
Volume 149, Issue -, Pages 60-76

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2018.01.004

Keywords

Hydrogen sulfide; Cystathionine beta-synthase; Cystathionine-lyase; Pancreatic beta cells; Insulin sensitivity; Insulin resistance; Diabetes mellitus; Obesity

Funding

  1. Medical University, Lublin, Poland [DS476]

Ask authors/readers for more resources

Insulin secretion and sensitivity play an essential role in maintaining normal glucose level and their abnormalities result in diabetes mellitus. H2S-synthesizing enzymes, CBS and/or CSE, are expressed in insulin-secreting pancreatic beta cells and H2S inhibits insulin secretion by activating ATP-sensitive K+ channels. In addition, H2S has been reported to have either pro- or antiapoptotic effects on 13 cells. Studies in the animal models suggest that excess of H2S in pancreatic islets may contribute to both type 1 and type 2 diabetes. H2S has also been demonstrated to regulate insulin sensitivity. In the liver, H2S stimulates gluconeogenesis and glycogenolysis and inhibits glucose utilization and glycogen storage. Its effect on insulin-stimulated glucose uptake in the adipose tissue is controversial; both stimulation and inhibition have been reported. H2S may also regulate adipose tissue lipolysis, adipokine production and inflammation; the processes important for local and systemic insulin sensitivity. Little is known about the effect of H2S on skeletal muscle metabolism. High fat diet, obesity and insulin resistance affect CBS/CSE/H2S system in the liver and adipose tissue, although the effect depends on diet composition, animals species and time of high-fat feeding. Most studies indicate that blood H2S concentration decreases in animal models of diabetes and in diabetic humans. (C) 2018 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Clinical Neurology

Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors

Klaudia Sapko, Anna Jamroz-Wisniewska, Michal Marciniec, Marcin Kulczynski, Anna Szczepanska-Szerej, Konrad Rejdak

NEUROLOGIA I NEUROCHIRURGIA POLSKA (2020)

Article Cell Biology

Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients

Anna Jamroz-Wisniewska, Jerzy Beltowski, Grazyna Wojcicka, Halina Bartosik-Psujek, Konrad Rejdak

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)

Article Biochemistry & Molecular Biology

Paraoxonase 1 Phenotype and Protein N-Homocysteinylation in Patients with Rheumatoid Arthritis: Implications for Cardiovascular Disease

Jolanta Parada-Turska, Grazyna Wojcicka, Jerzy Beltowski

ANTIOXIDANTS (2020)

Article Medicine, General & Internal

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients

Anna Jamroz-Wisniewska, Radoslaw Zajdel, Agnieszka Slowik, Monika Marona, Marcin Wnuk, Monika Adamczyk-Sowa, Bozena Adamczyk, Anetta Lasek-Bal, Przemyslaw Puz, Arkadiusz Steposz, Ewa Krzystanek, Maja Patalong-Ogiewa, Anna Pokryszko-Dragan, Slawomir Budrewicz, Dorota Koziarska, Anna Karbicka, Slawomir Wawrzyniak, Waldemar Fryze, Marzena Furtak-Niczyporuk, Konrad Rejdak

Summary: The study found that the NEDA-3 rate after the first year of therapy was higher for natalizumab compared to fingolimod. Patients with lower MRS on platform therapy had better outcomes when switching to second-line therapy. Early switching to second-line therapy may lead to better results for patients treated with natalizumab or fingolimod.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Environmental Sciences

Susac syndrome as a multidisciplinary diagnostic challenge

Klaudia Sapko, Anna Jamroz-Wisniewska, Anna Wozniak, Michal Marciniec, Marcin Kulczynski, Marzena Janczarek, Robert Rejdak, Konrad Rejdak

Summary: This case report describes a patient with Susac syndrome (SuS) who was diagnosed based on the clinical picture and test results. Despite treatment, the disease continued to progress. The importance of considering SuS as a potential cause for hearing loss or encephalopathy of unknown etiology is emphasized.

ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2022)

Review Public, Environmental & Occupational Health

NEUROPATHIC PAIN AND CHRONIC PAIN AS AN UNDERESTIMATED INTERDISCIPLINARY PROBLEM

Anna K. Szewczyk, Anna Jamroz-Wisniewska, Natalia Haratym, Konrad Rejdak

Summary: Neuropathic pain and chronic pain are interdisciplinary problems that involve medicine, psychology, sociology, and economics. The scale of this problem is increasing due to population aging and the growing incidence of lifestyle disorders. Occupational populations may also be affected by these diseases, impacting their quality of life, mental health, and work productivity. Proper assessment is crucial for determining the best treatment method.

INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH (2022)

Article Neurosciences

The Impact of Study Mode (Online vs. Hybrid) on Early Symptoms of Depression and Coping Strategies among University Students in Poland in Time of COVID-19 Pandemic-Preliminary Study

Anna Drelich-Zbroja, Anna Jamroz-Wisniewska, Maryla Kuczynska, Monika Zbroja, Weronika Cyranka, Katarzyna Drelich, Olga Pustelniak, Izabela Dabrowska, Katarzyna Markiewicz

Summary: The study found that the fully online study mode had a negative impact on the mental health of students during the COVID-19 pandemic, while hybrid students were more likely to use active and positive coping strategies. This suggests that implementing systemic psychological care is crucial in dealing with the significant psychological effects of the pandemic in the coming years.

BRAIN SCIENCES (2021)

Editorial Material Cardiac & Cardiovascular Systems

Microalbuminuria and the Risk of Mortality in Patients with Acute Heart Failure

Jerzy Beltowski

ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2022)

Article Immunology

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

Agata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, Marcin Wnuk, Monika Marona, Klaudia Nowak, Agnieszka Slowik, Anna Jamroz-Wisniewska, Konrad Rejdak, Beata Lech, Malgorzata Popiel, Iwona Rosciszewska-Zukowska, Adam Perenc, Halina Bartosik-Psujek, Mariola Swiderek-Matysiak, Malgorzata Siger, Agnieszka Ciach, Agata Walczak, Anna Jurewicz, Mariusz Stasiolek, Karolina Kania, Klara Dyczkowska, Alicja Kalinowska-Lyszczarz, Weronika Galus, Anna Walawska-Hrycek, Ewa Krzystanek, Justyna Chojdak-Lukasiewicz, Jakub Ubysz, Anna Pokryszko-Dragan, Katarzyna Kapica-Topczewska, Marcin Bazylewicz, Anna Mironczuk, Joanna Kulikowska, Jan Kochanowicz, Marta Bialek, Malgorzata Stolarz, Katarzyna Kubicka-Baczyk, Natalia Niedziela, Natalia Morawiec, Monika Adamczyk-Sowa, Aleksandra Podlecka-Pietowska, Monika Nojszewska, Beata Zakrzewska-Pniewska, Elzbieta Jasinska, Jacek Zaborski, Marta Milewska-Jedrzejczak, Jacek Zwiernik, Beata Zwiernik, Andrzej Potemkowski, Waldemar Brola, Alina Kulakowska

Summary: Vaccination against SARS-CoV-2 is safe for people with MS who are being treated with DMTs. Most adverse events following vaccination are mild and the acute relapse incidence is low.

VACCINES (2022)

Article Biochemistry & Molecular Biology

Effect of Exogenous Hydrogen Sulfide and Polysulfide Donors on Insulin Sensitivity of the Adipose Tissue

Jolanta Kowalczyk-Boltuc, Krzysztof Wiorkowski, Jerzy Beltowski

Summary: This study investigated the effects of hydrogen sulfide (H2S) and inorganic polysulfides on insulin sensitivity in adipose tissue. The results suggest that polysulfides may normalize insulin sensitivity, at least in the adipose tissue, in obesity/metabolic syndrome.

BIOMOLECULES (2022)

Article Clinical Neurology

Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland

Agata Czarnowska, Joanna Tarasiuk, Olga Zajkowska, Marcin Wnuk, Monika Marona, Klaudia Nowak, Agnieszka Slowik, Anna Jamroz-Wisniewska, Konrad Rejdak, Beata Lech, Malgorzata Popiel, Iwona Rosciszewska-Zukowska, Adam Perenc, Halina Bartosik-Psujek, Mariola Swiderek-Matysiak, Malgorzata Siger, Agnieszka Ciach, Agata Walczak, Anna Jurewicz, Mariusz Stasiolek, Karolina Kania, Klara Dyczkowska, Alicja Kalinowska-Lyszczarz, Weronika Galus, Anna Walawska-Hrycek, Ewa Krzystanek, Justyna Chojdak-Lukasiewicz, Jakub Ubysz, Anna Pokryszko-Dragan, Katarzyna Kapica-Topczewska, Monika Chorazy, Marcin Bazylewicz, Anna Mironczuk, Joanna Kulikowska, Jan Kochanowicz, Marta Bialek, Malgorzata Stolarz, Katarzyna Kubicka-Baczyk, Natalia Niedziela, Pawel Warmus, Monika Adamczyk-Sowa, Aleksandra Podlecka-Pictowska, Monika Nojszewska, Beata Zakrzewska-Pniewska, Elzbieta Jasinska, Jacek Zaborski, Marta Milewska-Jedrzejczak, Jacek Zwiernik, Beata Zwiernik, Andrzej Potemkowski, Waldemar Brola, Alina Kulakowska

Summary: This study evaluated the side effects of COVID-19 vaccination among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs). The results showed that vaccination is safe and can help reduce hesitancy towards vaccination among MS patients.

FRONTIERS IN NEUROLOGY (2022)

Review Medicine, General & Internal

Novel Drugs in a Pipeline for Progressive Multiple Sclerosis

Klaudia Sapko, Anna Jamroz-Wisniewska, Konrad Rejdak

Summary: Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. The pathogenesis of progressive MS (PMS) is complex and causes therapeutic difficulties. The efficacy of currently available anti-inflammatory drugs for PMS is limited in time. In search of innovative solutions, several research studies have evaluated the effectiveness of drugs with neuroprotective or remyelinating effects in PMS. This review discusses the compounds that have entered the clinical assessment phase and explores future prospects for successful PMS treatment.

JOURNAL OF CLINICAL MEDICINE (2022)

Editorial Material Peripheral Vascular Disease

Role of Endothelial-to-Mesenchymal Transition in Kidney Injury Associated With Salt-Sensitive Hypertension

Jerzy Beltowski

AMERICAN JOURNAL OF HYPERTENSION (2023)

Review Health Care Sciences & Services

Facial Diplegia-Complication or Manifestation of SARS-CoV-2 Infection? A Case Report and Systemic Literature Review

Anna K. Szewczyk, Urszula Skrobas, Anna Jamroz-Wisniewska, Krystyna Mitosek-Szewczyk, Konrad Rejdak

Summary: Since the outbreak of the new coronavirus, some patients have experienced neurological issues such as bilateral facial nerve palsy and progressive ascending paresis of the limbs, but most cases have favorable outcomes. Symptoms of nerve damage related to COVID-19 may be linked to facial nerve damage, highlighting the importance of studying the virus's impact on the nervous system.

HEALTHCARE (2021)

Article Medicine, General & Internal

A Retrospective Analysis of Pain Etiology in Middle-Aged Patients with Peripheral Neuropathy

Anna K. Szewczyk, Anna Jamroz-Wisniewska, Konrad Rejdak

Summary: This study found a high incidence of peripheral neuropathy in middle-aged individuals, with a slightly higher prevalence in women than men. The occurrence of pain was correlated with disease progression/severity in subacute type and small fiber neuropathy.

MEDICINA-LITHUANIA (2021)

Article Pharmacology & Pharmacy

Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib

Paola Orlandi, Marta Banchi, Francesca Vaglini, Marco Carli, Stefano Aringhieri, Arianna Bandini, Carla Pardini, Cristina Viaggi, Michele Lai, Greta Ali, Alessandra Ottani, Eleonora Vandini, Patrizia Guidi, Margherita Bernardeschi, Veronica La Rocca, Giulio Francia, Gabriella Fontanini, Mauro Pistello, Giada Frenzilli, Daniela Giuliani, Marco Scarselli, Guido Bocci

Summary: This study investigates the role of MC4R in melanoma and the use of the selective antagonist ML in combination with vemurafenib. The results show that ML can inhibit melanoma cell proliferation and induce apoptosis through the inhibition of ERK1/2 phosphorylation and reduction of BCL-XL expression. The combination of vemurafenib and ML exhibits a synergistic effect in vitro and inhibits tumor growth in vivo without causing adverse effects.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Cardiac human bitter taste receptors contain naturally occurring variants that alter function

Conor J. Bloxham, Katina D. Hulme, Fabrizio Fierro, Christian Fercher, Cassandra L. Pegg, Shannon L. O'Brien, Simon R. Foster, Kirsty R. Short, Sebastian G. B. Furness, Melissa E. Reichelt, Masha Y. Niv, Walter G. Thomas

Summary: Bitter taste receptors (T2Rs) are a type of G protein-coupled receptors that allow humans to detect aversive and toxic substances. This study characterized the functional properties of previously identified T2Rs in human cardiac tissues and their naturally occurring polymorphisms. The results showed differences in signaling among different T2R variants, and revealed a potential association between the T2R50 Tyr203 variant and cardiovascular disease.

BIOCHEMICAL PHARMACOLOGY (2024)

Article Pharmacology & Pharmacy

Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma

Lu Chen, Huanying Shi, Wenxin Zhang, Yongjun Zhu, Haifei Chen, Zimei Wu, Huijie Qi, Jiafeng Liu, Mingkang Zhong, Xiaojin Shi, Tianxiao Wang, Qunyi Li

Summary: This study demonstrates that Carfilzomib exhibits potent anti-tumor activity against esophageal squamous cell carcinoma (ESCC) by triggering mitochondrial apoptosis and reprogramming cellular metabolism. It has been identified that activating transcription factor 3 (ATF3) plays a crucial role as a cellular target in ESCC cells treated with Carfilzomib. Overexpression of ATF3 effectively counteracts the effects of Carfilzomib on ESCC cell proliferation, apoptosis, and metabolic reprogramming. Furthermore, ATF3 mediates the anti-tumor activity of Carfilzomib, suggesting its potential as a therapeutic agent for ESCC.

BIOCHEMICAL PHARMACOLOGY (2024)

Review Pharmacology & Pharmacy

Ferroptosis resistance in cancer: recent advances and future perspectives

Xing Zhang, Xiang Li, Ran Xia, Hong-Sheng Zhang

Summary: This review summarizes recent progress on the mechanisms of ferroptosis resistance in cancer and highlights the role of redox status and metabolism. Combination therapy for ferroptosis has great potential in treating resistant malignant tumors.

BIOCHEMICAL PHARMACOLOGY (2024)